StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.30−0.02 (-1.52%)

Close on Nov 20, 2026Market cap $29.47MP/E –Yield –

BioHarvest Sciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $20.48M, up 46.9% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.48M+46.9%
FY2024Dec 31, 2024$13.94M+147.5%
FY2023Dec 31, 2023$5.63M–

More BioHarvest Sciences figures

See a number that looks wrong?